Amended Statement of Ownership (sc 13g/a)
January 14 2021 - 03:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)*
Under the Securities Exchange Act of 1934
AMERICAN BIO MEDICA CORPORATION
(Name of Issuer)
Common Stock, $ .01 par value
(Title of Class of Securities)
024600 10 8
(CUSIP Number)
December 31, 2020
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
|
¨ |
Rule 13d-1(b) |
|
x |
Rule 13d-1(c) |
|
¨ |
Rule 13d-1(d) |
* The remainder of this cover page shall be filled
out for a reporting person's initial filing on this form with
respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. 024600 10
8 |
13G |
|
|
|
|
|
|
1. |
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Stuart Sternberg
XXXXXXXXXX
|
|
|
2. |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A
GROUP
(see instructions)
(a) ¨
(b) ¨ Not Applicable. |
|
|
3. |
|
SEC USE ONLY
|
|
|
4. |
|
CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A. |
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH
REPORTING PERSON WITH |
|
5. |
|
SOLE VOTING POWER
1,893,932 |
|
6. |
|
SHARED VOTING POWER
0 |
|
7. |
|
SOLE DISPOSITIVE POWER
1,893,932 |
|
8. |
|
SHARED DISPOSITIVE POWER
0 |
9. |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
1,893,932 |
|
|
10. |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
(see instructions) ¨ |
|
|
11. |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(9)
5.02% based on 37,703,467 outstanding shares as of December 29,
2020 reported in the issuer’s 424(b)(3) filed with the SEC on
January 12, 2021 |
|
|
12. |
|
TYPE OF REPORTING PERSON (see instructions)
IN |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CUSIP No.
024600 10 8 |
13G/A |
|
Item 1.
|
(a) |
Name of
Issuer
American Bio Medica Corporation |
|
|
|
|
(b) |
Address of Issuer’s Principal Executive Offices
122 Smith Road
Kinderhook, New York 12106
|
|
|
|
Item 2.
|
(a) |
Name of Person
Filing
Stuart Sternberg |
|
|
|
|
(b) |
Address of the Principal Office or, if none, residence
555 5th Ave NE, Unit 1043
St Petersburg FL 33701
|
|
|
|
|
(c) |
Citizenship
U.S.A. |
|
|
|
|
(d) |
Title of Class of Securities
Common Stock, $.01 par value |
|
|
|
|
(e) |
CUSIP Number
024600 10 8 |
|
|
|
Item 3. If this statement is filed pursuant to
§§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person
filing is a:
|
(a) |
¨ |
Broker or
dealer registered under section 15 of the Act (15 U.S.C.
78o). |
|
|
|
|
|
(b) |
¨ |
Bank as defined in section
3(a)(6) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(c) |
¨ |
Insurance company as defined in
section 3(a)(19) of the Act (15 U.S.C. 78c). |
|
|
|
|
|
(d) |
¨ |
Investment company registered
under section 8 of the Investment Company Act of 1940 (15 U.S.C.
80a-8). |
|
|
|
|
|
(e) |
¨ |
An investment adviser in
accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
|
|
(f) |
¨ |
An employee benefit plan or
endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F); |
|
|
|
|
|
(g) |
¨ |
A parent holding company or
control person in accordance with
§240.13d-1(b)(1)(ii)(G); |
|
|
|
|
|
(h) |
¨ |
A savings associations as defined
in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813); |
|
|
|
|
|
(i) |
¨ |
A church plan that is excluded
from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C.
80a-3); |
|
|
|
|
|
(j) |
¨ |
Group, in accordance with
§240.13d-1(b)(1)(ii)(J). |
Item 4. Ownership.
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified
in Item 1.
|
|
|
|
|
|
(a) |
|
Amount beneficially
owned: 1,893,932 |
|
|
|
|
|
|
(b) |
|
Percent of
class: 5.02% based on 37,703,467 outstanding shares as
of December 29, 2020 reported in the issuer’s 424(b)(3) filed with
the SEC on January 12, 2021 |
|
|
|
|
|
|
(c) |
|
Number of shares as
to which the person has: |
|
|
|
|
|
|
|
|
(i) |
Sole power to vote or to direct
the vote: 1,893,932 |
|
|
|
|
|
|
|
|
(ii) |
Shared power to vote or to direct
the vote: 0 |
|
|
|
|
|
|
|
|
(iii) |
Sole power to dispose or to
direct the disposition of: 1,893,932 |
|
|
|
|
|
|
|
|
(iv) |
Shared power to dispose or to
direct the disposition of: 0 |
|
|
|
|
|
Item 5. Ownership of Five Percent or Less of a
Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following ¨.
Item 6. Ownership of More than Five Percent on Behalf
of Another Person.
Not applicable.
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members
of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
CUSIP No.
024600 10 8 |
13G |
|
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
|
January 14, 2021
Date
|
|
|
|
/s/ Stuart Sternberg
Signature
|
|
|
|
Stuart Sternberg
Name/Title
|